✦ LIBER ✦

Calibration and field evaluation of polar organic chemical integrative sampler (POCIS) for monitoring pharmaceuticals in hospital wastewater

✍ Scribed by Bailly, Emilie; Levi, Yves; Karolak, Sara

Book ID: 120469605
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 378 KB
Volume: 174
Category: Article
ISSN: 0269-7491
DOI: 10.1016/j.envpol.2012.10.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polar organic chemical integrative sampl

Polar organic chemical integrative sampler (POCIS): application for monitoring organic micropollutants in wastewater effluent and surface water

✍ Miège, Cécile ;Budzinski, Hélène ;Jacquet, Romain ;Soulier, Coralie ;Pelte, Thom 📂 Article 📅 2012 🏛 Royal Society of Chemistry 🌐 English ⚖ 390 KB

Chemical calibration, performance, valid

Chemical calibration, performance, validation and applications of the polar organic chemical integrative sampler (POCIS) in aquatic environments

✍ Nicolas Morin; Cécile Miège; Marina Coquery; Jérôme Randon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 397 KB

Laboratory calibration and field deploym

Laboratory calibration and field deployment of the Polar organic chemical integrative sampler for pharmaceuticals and personal care products in wastewater and surface water

✍ Sherri L. MacLeod; Evelyn L. McClure; Charles S. Wong 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

Evaluating the polar organic chemical in

Evaluating the polar organic chemical integrative sampler for the monitoring of beta-blockers and hormones in wastewater treatment plant effluents and receiving surface waters

✍ Romain Jacquet; Cécile Miège; Philippe Bados; Séverine Schiavone; Marina Coquery 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

## Abstract Wastewater treatment plants (WWTP) are known to be a source of surface water contamination by organic compounds such as pharmaceuticals. The objective of the present work was to study the suitability of the polar organic chemical integrative sampler (POCIS) to monitor beta‐blockers and